SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,452,165,468 | +10.2% | 44,554,162 | 0.0% | 54.48% | +9.8% |
Q2 2023 | $8,574,894,019 | -9.7% | 44,554,162 | -5.0% | 49.62% | -4.0% |
Q1 2023 | $9,498,630,809 | +57.6% | 46,913,769 | +0.0% | 51.68% | +42.7% |
Q4 2022 | $6,028,695,304 | -6.1% | 46,912,266 | 0.0% | 36.20% | -13.9% |
Q3 2022 | $6,419,005,000 | -22.7% | 46,912,266 | 0.0% | 42.04% | -10.7% |
Q2 2022 | $8,300,656,000 | +22.8% | 46,912,266 | 0.0% | 47.09% | +21.3% |
Q1 2022 | $6,757,712,000 | -6.8% | 46,912,266 | +0.0% | 38.83% | +10.1% |
Q4 2021 | $7,249,714,000 | -9.7% | 46,893,364 | -0.8% | 35.27% | +0.0% |
Q3 2021 | $8,029,546,000 | +7.6% | 47,288,259 | 0.0% | 35.26% | +7.5% |
Q2 2021 | $7,465,870,000 | +13.7% | 47,288,259 | +0.0% | 32.79% | +15.2% |
Q1 2021 | $6,564,018,000 | -20.7% | 47,270,759 | +0.0% | 28.46% | -8.8% |
Q4 2020 | $8,278,767,000 | -10.5% | 47,269,424 | 0.0% | 31.19% | -15.6% |
Q3 2020 | $9,250,154,000 | – | 47,269,424 | – | 36.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |